Releases
JNJ
158.19
+0.15%
0.23
  • All
  • Financials
  • Insiders
More
Webull provides the latest Johnson & Johnson (JNJ) stock and general news. This information may help you make smarter investment decisions.
About JNJ
Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through two segments: Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.